Table 2 Demographic characteristics and frequency of ICSRs per antigen or vaccine
Variable | Total ICSRs (N = 272) n (%)a | Vaccine | P value | |||||
|---|---|---|---|---|---|---|---|---|
BCG (N = 16) n (%)a | Measles (N = 93) n(%)a | Measles inappropriate (N = 40) n (%)a | OPV/DTP booster (N = 7) n (%)a | OPV/DTP-Hib-HepB (N = 107) n (%)a | Unclassified (N = 9) n (%)a | |||
ICSR completeness Mean ± SE | 0.81 ± 0.01 | 0.79 ± 0.04 | 0.82 ± 0.02 | 0.87 ± 0.01 | 0.82 ± 0.05 | 0.79 ± 0.02 | 0.61 ± 0.04 | < 0.0001 |
Gender | ||||||||
Male | 150 (55.3) | 7 (43.7) | 55 (59.8) | 22(55.0) | 4 (57.1) | 59 (55.1) | 3(33.3) | 0.641 |
Female | 121(44.7) | 9(56.3) | 37(40.2) | 18 (45.0) | 3(42.9) | 48 (44.9) | 6(66.7) | |
Male: female Ratio | 1.24 | 0.78 | 1.49 | 1.22 | 1.33 | 1.23 | 0.50 | |
Age (months) | ||||||||
Median | 12 | 2.5 | 72 | 17 | 60 | 5 | 5 | < 0.0001 |
Range | 0–168 | 0–11 | 9–168 | 4–48 | 17–60 | 0–12 | 3–6 | |
Number of AEFIsb | 387 (100.0) | 20(5.2) | 136(35.1) | 60(15.5) | 10(2.6) | 152(39.3) | 9(2.3) | < 0.0001 |
AEFI/ICSR ratio | 1.42 | 1.25 | 1.46 | 1.50 | 1.43 | 1.42 | 1.00 | |
Severity of ICSR | ||||||||
Serious | 30(11.0) | 2(12.5) | 6(6.5) | 7(17.5) | 1 (14.3) | 14(13.1) | 0(0.0) | 0.371 |
Not serious | 242(89.0) | 14(87.5) | 87(93.5) | 33(82.5) | 6(85.7) | 93(86.9) | 9(100.0) | |
Seriousness of ICSR | ||||||||
Prolonged Hospitalisation | 4(1.5) | 0(0.0) | 1(1.1) | 0(0.0) | 0(0.0) | 3(2.8) | 0(0.0) | 0.051 |
Life Threatening | 10(3.7) | 0(0.0) | 3(3.2) | 4(10.0) | 1(14.3) | 2(1.9) | 0(0.0) | 0.156 |
Death | 16(5.9) | 2(12.5) | 2(2.2) | 3(7.5) | 0(0.0) | 9 (8.4) | 0(0.0) | 0.001 |